Magle Chemoswed Holding AB (publ) (STO:MAGLE)
17.40
-0.90 (-4.92%)
At close: Dec 5, 2025
STO:MAGLE Revenue
Magle Chemoswed Holding AB had revenue of 74.91M SEK in the quarter ending September 30, 2025, with 12.24% growth. This brings the company's revenue in the last twelve months to 300.49M, up 43.63% year-over-year. In the year 2024, Magle Chemoswed Holding AB had annual revenue of 240.57M with 40.27% growth.
Revenue (ttm)
300.49M
Revenue Growth
+43.63%
P/S Ratio
1.20
Revenue / Employee
2.09M
Employees
147
Market Cap
359.30M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 240.57M | 69.07M | 40.27% |
| Dec 31, 2023 | 171.50M | 23.51M | 15.89% |
| Dec 31, 2022 | 147.98M | 15.84M | 11.98% |
| Dec 31, 2021 | 132.15M | -10.19M | -7.16% |
| Dec 31, 2020 | 142.34M | 10.55M | 8.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Medicover AB | 25.67B |
| Elekta AB | 17.57B |
| Asker Healthcare Group AB | 16.41B |
| AddLife AB | 10.53B |
| Nolato AB | 9.57B |
| Vitrolife AB | 3.51B |